These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16044009)

  • 61. High frequency of HIV-1 infections with multiple HIV-1 strains in men having sex with men (MSM) in Senegal.
    Leye N; Vidal N; Ndiaye O; Diop-Ndiaye H; Wade AS; Mboup S; Delaporte E; Toure-Kane C; Peeters M
    Infect Genet Evol; 2013 Dec; 20():206-14. PubMed ID: 24035811
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of a novel circulating recombinant form (CRF) 36_cpx in Cameroon that combines two CRFs (01_AE and 02_AG) with ancestral lineages of subtypes A and G.
    Powell RL; Zhao J; Konings FA; Tang S; Nanfack A; Burda S; Urbanski MM; Saa DR; Hewlett I; Nyambi PN
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1008-19. PubMed ID: 17725418
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HIV-1 genetic variants in the Russian Far East.
    Kazennova E; Laga V; Lapovok I; Glushchenko N; Neshumaev D; Vasilyev A; Bobkova M
    AIDS Res Hum Retroviruses; 2014 Aug; 30(8):742-52. PubMed ID: 24773167
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diversity of HIV in rural Burkina Faso.
    Tebit DM; Ganame J; Sathiandee K; Nagabila Y; Coulibaly B; Krausslich HG
    J Acquir Immune Defic Syndr; 2006 Oct; 43(2):144-52. PubMed ID: 16951652
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants.
    Dowling WE; Kim B; Mason CJ; Wasunna KM; Alam U; Elson L; Birx DL; Robb ML; McCutchan FE; Carr JK
    AIDS; 2002 Sep; 16(13):1809-20. PubMed ID: 12218394
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.
    Stefic K; Bouvin-Pley M; Essat A; Visdeloup C; Moreau A; Goujard C; Chaix ML; Braibant M; Meyer L; Barin F
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404804
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular characterization of non-B HIV type 1 subtypes from Africa in Spain.
    Ortiz M; Muñoz L; Bernal A; Rodriguez A; Zorraquino A; Vadillo J; Salas A; Moreno A; García-Sáiz A
    AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1967-71. PubMed ID: 11153079
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cocirculation of several similar but unique HIV-1 recombinant forms in Guinea-Bissau revealed by near full-length genomic sequencing.
    Palm AA; Esbjörnsson J; Månsson F; Biague A; da Silva ZJ; Norrgren H; Jansson M; Medstrand P
    AIDS Res Hum Retroviruses; 2015 Sep; 31(9):938-45. PubMed ID: 26066756
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Postmortem Molecular Epidemiology of HIV-1 Strains Isolated in Turkey].
    Ziyade N; Sayan M; Elgörmüş N; Büyük Y
    Mikrobiyol Bul; 2019 Oct; 53(4):374-387. PubMed ID: 31709935
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3.
    Meloni ST; Kim B; Sankalé JL; Hamel DJ; Tovanabutra S; Mboup S; McCutchan FE; Kanki PJ
    J Virol; 2004 Nov; 78(22):12438-45. PubMed ID: 15507630
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genetic barrier to the development of resistance to rilpivirine and etravirine between HIV-1 subtypes CRF02_AG and B.
    Fofana DB; Soulie C; Maiga AI; Fourati S; Malet I; Wirden M; Tounkara A; Traore HA; Calvez V; Marcelin AG; Lambert-Niclot S
    J Antimicrob Chemother; 2013 Nov; 68(11):2515-20. PubMed ID: 23833185
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A sudden epidemic of HIV type 1 among injecting drug users in the former Soviet Union: identification of subtype A, subtype B, and novel gagA/envB recombinants.
    Bobkov A; Kazennova E; Selimova L; Bobkova M; Khanina T; Ladnaya N; Kravchenko A; Pokrovsky V; Cheingsong-Popov R; Weber J
    AIDS Res Hum Retroviruses; 1998 May; 14(8):669-76. PubMed ID: 9618078
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG.
    Montavon C; Toure-Kane C; Liegeois F; Mpoudi E; Bourgeois A; Vergne L; Perret JL; Boumah A; Saman E; Mboup S; Delaporte E; Peeters M
    J Acquir Immune Defic Syndr; 2000 Apr; 23(5):363-74. PubMed ID: 10866228
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Human immunodeficiency virus type 1 subtypes in Djibouti].
    Abar AE; Jlizi A; Darar HY; Ben Nasr M; Abid S; Kacem MA; Slim A
    Arch Inst Pasteur Tunis; 2012; 89(1-4):33-7. PubMed ID: 24834659
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3/CRF02_AG compared with sub-subtype A3.
    Palm AA; Esbjörnsson J; Månsson F; Kvist A; Isberg PE; Biague A; da Silva ZJ; Jansson M; Norrgren H; Medstrand P
    J Infect Dis; 2014 Mar; 209(5):721-8. PubMed ID: 23935204
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cognitive Function Among Antiretroviral Treatment-Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria.
    Jumare J; Ndembi N; El-Kamary SS; Magder L; Hungerford L; Burdo T; Eyzaguirre LM; Dakum P; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
    Clin Infect Dis; 2018 Apr; 66(9):1448-1453. PubMed ID: 29182762
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools.
    Pineda-Peña AC; Faria NR; Imbrechts S; Libin P; Abecasis AB; Deforche K; Gómez-López A; Camacho RJ; de Oliveira T; Vandamme AM
    Infect Genet Evol; 2013 Oct; 19():337-48. PubMed ID: 23660484
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study.
    Giuliani M; Santoro MM; Lo Presti A; Cella E; Scognamiglio P; Lai A; Latini A; Fabeni L; Gori C; Pinnetti C; Girardi E; Perno CF; Zehender G; Ciccozzi M
    Biomed Res Int; 2013; 2013():810617. PubMed ID: 24369538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.